Proton pump inhibitors and risk of hearing loss; a systematic review
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Proton pump inhibitors (PPIs) are widely used medications for the treatment of gastroesophageal reflux disease (GERD) and other conditions requiring acid suppression. While generally considered safe, concerns have emerged regarding potential long-term adverse effects of PPIs, such as ototoxicity. To systematically synthesize the evidence regarding the association between PPIs usage and the risk of hearing loss. This systematic review followed PRISMA guidelines. PubMed/Medline, Embase, Scopus, and Web of Science databases were searched in May 2024 and further updated using a handsearching in December 2024. Clinical original studies evaluating the relationship between PPI usage and any type of hearing impairments were included. Exclusion criteria include non-human studies, non-English language publications, reviews, case reports, book chapters, conference abstracts, and retracted studies. Risk of bias was assessed using the Joanna Briggs Institute (JBI) critical appraisal tools. The initial database search yielded 661 records. Four studies (total n = 208,956 participants) proceeded to full-text review and were included in the qualitative synthesis. All of the included studies demonstrated a statistically significant association between PPI use and an increased risk of hearing impairments; even after adjusting for possible confounders; however, one study found no independent association after adjusting for GERD symptoms. The findings of this systematic review reveal inconclusive results regarding the association between PPI use and hearing loss. While the limited available evidence suggests a possible increased risk, further research is needed to dissect the possible causal relationship and elucidate the underlying mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Rayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092
Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Gerson, L. B., & Vela, M. F. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.444 · Cited by 1,767
Agrawal, Y. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.14.1522 · Cited by 977
Proton pump inhibitors alter the composition of the gut microbiota
Jackson, M. A., Goodrich, J. K., Maxan, M.-E., Freedberg, D. E., Abrams, J. A., Poole, A. C., Sutter, J. L., Welter, D., Ley, R. E., Bell, J. T., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310861 · Cited by 895
Chiba, N., De Gara, C., Wilkinson, J., & Hunt, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9178669 · Cited by 857
Gomm, W., von Holt, K., Thomé, F., Broich, K., Maier, W., Fink, A., Doblhammer, G., & Haenisch, B. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4791 · Cited by 563
Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis
Janarthanan, S., Ditah, I., Adler, D. G., & Ehrinpreis, M. N. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.179 · Cited by 538
Moayyedi, P., Eikelboom, J. W., Bosch, J., Connolly, S. J., Dyal, L., Shestakovska, O., Leong, D., Anand, S. S., Störk, S., Branch, K. R. H., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.056 · Cited by 483
Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD
Xie, Y., Bowe, B., Li, T., Xian, H., Balasubramanian, S., & Al-Aly, Z. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121377 · Cited by 337
Research works printed but not linked: 2
- Makhoul E, Waked H (2018) Proton pump inhibitor use and vitamin B12 deficiency in a lebanese population. Int J Dev Res 08:4
- Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K (2017) Chapter 7: Systematic reviews of etiology and risk. Joanna briggs institute reviewer’s manual. The Joanna Briggs Institute 5:217–269
Cited by
The pharmacological effects and therapeutic potential of flavonoids in digestive diseases
Xu, J., Zhang, J. C., Yu, B., Liu, C., & Zhang, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1684377 · Cited by 2
Teng, M., Luo, X., Zhang, P., Yang, C., Ma, Y., & Liu, X. (2026) · BMEMat · doi:10.1002/bmm2.70066 · Cited by 1
Metadata
- Authors
- Khadivi, A., Amiri, F., Radnia, P., Salehi-pourmehr, H., Mirzaei Bavil, F., Pakkhesal, S., Hamzehzadeh, S., Moghaddam, Y. J., & Naseri, A.
- Affiliations
- Tabriz University of Medical Sciences (IR)
- Corresponding author
- Moghaddam, Yalda Jabbari
- Naseri, Amirreza
- ORCID
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 2025-05-09
- Volume
- 398
- Issue
- 10
- Pages
- 13567-13580
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- OpenAlex
- W4410240970
- Semantic Scholar
- 640177c0722e4754c8af91561b6544f48b56748e
- Cited by
- 2
- References
- 67
- Citations by year
- 2026: 2
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tabriz University of Medical Sciences (74439)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
- Health Sciences › Health Professions › Speech and Hearing › Hearing Loss and Rehabilitation
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Keywords
- proton pump inhibitors, hearing loss, ototoxicity, gastroesophageal reflux disease, acid suppression, adverse drug reactions, chronic drug administration
- MeSH terms
- Gastroesophageal Reflux, Humans, Risk Factors, Hearing Loss, Proton Pump Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proton pump inhibitors and risk of hearing loss; a systematic review. https://app.cochat.ai/papers/10.1007/s00210-025-04241-5
- The paper
- Khadivi, A., Amiri, F., Radnia, P., Salehi-pourmehr, H., Mirzaei Bavil, F., Pakkhesal, S., Hamzehzadeh, S., Moghaddam, Y. J., & Naseri, A. (2025). Proton pump inhibitors and risk of hearing loss; a systematic review. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04241-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.